Nsg533 nsg 533 exam Study guides, Class notes & Summaries

Exam 2: NSG533 / NSG 533 (Latest 2024 / 2025 Update) Advanced Pharmacology Exam Review | Complete Guide with Questions and Verified Answers | 100% Correct - Wilkes Q: How does Tramadol work? Answer: It is a centrally acting synthetic opioid with weak SSRI/SNRI activity. Q: What are the daily dose limits for Tramadol? Answer: Maximum of 200mg per day. Q: What are the potential interactions of Tramadol? Answer: Increased risk of seizures with TCAs and other SSRIs, risk for serotonin syndrome. Q: W...

NSG533| NSG 533 Advanced Pharmacology 2024 Exam Questions and Answers NSG533| NSG 533 Advanced Pharmacology 2024 Exam Questions and Answers

Exam 3: NSG533 / NSG 533 (Latest 2024 / 2024 Update) Advanced Pharmacology Exam Review | Guide with Questions and Verified Answers | 100% Correct - Wilkes Q: Short-acting muscarinic antagonist (SAMA) Answer: Ipratropium Q: avoid co administration of ICS with which CYP3A4 inhibitors? (may cause cushing's) Answer: ritonavir, itraconazole, ketoconazole Q: lack of response to ICS may be indicative of what? Answer: CLCCl1 gene Q: LABAs Answer: Salmeterol Formoterol Vilanterol Q: LAMAs Answer: tiotro...

Exam 3: NSG533/ NSG 533 (Latest 2023/ 2024 Update) Advanced Pharmacology Exam Review| Guide with Questions and Verified Answers| 100% Correct Q: Short-acting muscarinic antagonist (SAMA) Answer: Ipratropium Q: avoid co administration of ICS with which CYP3A4 inhibitors? (may cause cushing's) Answer: ritonavir, itraconazole, ketoconazole Q: lack of response to ICS may be indicative of what? Answer: CLCCl1 gene Q: LABAs Answer: Salmeterol Formotero...

Exam 3: NSG533 / NSG 533 (Latest 2024 / 2025) Advanced Pharmacology Complete Review | Questions and Verified Answers | 100% Correct | Grade A - Wilkes Q: Long-acting Inhaled B2-agonists Answer: -Provide 12-24 hours of bronchodilation after single dose -Useful for nocturnal symptoms -Chronic treatment for asthma as ADD-ON therapy for patients not controlled on low-medium dose of ICS -Helps reduce ICS amount necessary for control *-Not to be used a monotherapy (risk for severe attack)* -Salmeterol...

Exam 2: NSG533 / NSG 533 (Latest 2024 / 2025 Update) Advanced Pharmacology Exam | Questions and Verified Answers | 100% Correct | Grade A - Wilkes Q: When are ACEIs or ARBs added in treatment of CS/carotid artery disease? Answer: When thiazide diuretics and CCBs fail to achieve treatment goals. Q: When do you start anti-platelet therapy in patients with CS/carotid artery disease? Answer: Symptomatic for 21 days or more Q: What medication and dose are preferred anti-platelet's for CS/carotid art...